Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HSCS HeartSciences	$3.65 -1.6%	$3.77	$2.36 ▼ $6.47	$8.46M	2.56	131,949 shs	81,588 shs
PAVM PAVmed	$0.47 +11.3%	$0.55	$0.30 ▼ $1.90	$9.23M	1.08	260,183 shs	386,044 shs
SSKN Strata Skin Sciences	$1.77 +1.1%	$2.12	$1.67 ▼ $3.79	$7.30M	0.66	14,999 shs	18,214 shs
USAQ QHSLab	$0.19	$0.20	$0.08 ▼ $0.47	$2.01M	0.48	2,984 shs	6,350 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HSCS HeartSciences	-1.59%	+6.00%	-4.38%	-6.31%	+3.63%
PAVM PAVmed	+0.26%	-7.74%	-28.42%	-34.93%	-42.30%
SSKN Strata Skin Sciences	-1.96%	-3.31%	-18.22%	-32.43%	-35.90%
USAQ QHSLab	0.00%	+0.53%	+5.56%	-25.58%	+27.09%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HSCS HeartSciences	3.2778 of 5 stars	3.5	5.0	0.0	3.0	0.8	0.6
PAVM PAVmed	4.6475 of 5 stars	3.5	5.0	4.3	2.6	0.0	1.9
SSKN Strata Skin Sciences	2.6656 of 5 stars	3.5	3.0	0.0	1.8	1.7	0.6
USAQ QHSLab	0.4988 of 5 stars	0.0	3.0	0.0	1.7	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HSCS HeartSciences	3.00	Buy	$13.00	256.16% Upside
PAVM PAVmed	3.00	Buy	$19.00	3,954.63% Upside
SSKN Strata Skin Sciences	3.00	Buy	$6.00	238.98% Upside
USAQ QHSLab	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest USAQ, HSCS, PAVM, and SSKN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
6/6/2025	PAVM PAVmed	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$19.50 ➝ $19.00

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HSCS HeartSciences	N/A	N/A	N/A	N/A	$0.18 per share	N/A
PAVM PAVmed	$2.99M	3.44	N/A	N/A	$0.16 per share	2.93
SSKN Strata Skin Sciences	$33.56M	0.22	N/A	N/A	$0.07 per share	25.29
USAQ QHSLab	$2.13M	0.94	N/A	N/A	($0.06) per share	-3.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HSCS HeartSciences	-$8.77M	-$9.36	N/A	N/A	N/A	N/A	-293.60%	-135.39%	9/11/2025 (Estimated)
PAVM PAVmed	$39.79M	$1.16	0.40	N/A	N/A	7,144.80%	N/A	-20.96%	N/A
SSKN Strata Skin Sciences	-$10.09M	-$2.84	N/A	N/A	N/A	-35.13%	-266.94%	-32.66%	N/A
USAQ QHSLab	-$260K	-$0.04	N/A	∞	N/A	-15.33%	N/A	-21.37%	N/A

Latest USAQ, HSCS, PAVM, and SSKN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/11/2025	N/A	HSCS HeartSciences	-$2.41	N/A	N/A	N/A	N/A	N/A
8/13/2025	Q2 2025	SSKN Strata Skin Sciences	-$0.27	-$0.60	-$0.33	-$0.60	$8.56 million	$7.70 million
7/24/2025	Q4 2025	HSCS HeartSciences	-$2.51	-$1.88	+$0.63	-$1.88	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HSCS HeartSciences	N/A	N/A	N/A	N/A	N/A
PAVM PAVmed	N/A	N/A	N/A	N/A	N/A
SSKN Strata Skin Sciences	N/A	N/A	N/A	N/A	N/A
USAQ QHSLab	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HSCS HeartSciences	N/A	0.59	0.41
PAVM PAVmed	N/A	0.52	0.37
SSKN Strata Skin Sciences	49.58	0.98	0.87
USAQ QHSLab	N/A	0.16	0.13

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HSCS HeartSciences	17.24%
PAVM PAVmed	19.93%
SSKN Strata Skin Sciences	32.43%
USAQ QHSLab	N/A

Insider Ownership

Company	Insider Ownership
HSCS HeartSciences	1.80%
PAVM PAVmed	7.30%
SSKN Strata Skin Sciences	39.00%
USAQ QHSLab	74.19%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HSCS HeartSciences	10	2.28 million	2.24 million	Not Optionable
PAVM PAVmed	90	21.93 million	20.33 million	Optionable
SSKN Strata Skin Sciences	120	4.17 million	2.54 million	Not Optionable
USAQ QHSLab	5	10.59 million	2.73 million	Not Optionable

USAQ, HSCS, PAVM, and SSKN Headlines

Recent News About These Companies

Short Interest in QHSLab, Inc. (OTCMKTS:USAQ) Expands By 45.5%

August 21 at 2:59 AM | americanbankingnews.com

QHSLab (OTCMKTS:USAQ) Trading Down 13.3% - What's Next?

August 13, 2025 | americanbankingnews.com

QHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health Services

July 8, 2025 | globenewswire.com

QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency

June 3, 2025 | globenewswire.com

QHSLab Enters Advanced Talks for Debt Restructuring

May 16, 2025 | tipranks.com

QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth

May 16, 2025 | globenewswire.com

Investing in Smarter Healthcare: The New Era of AI-Driven Medicine

May 15, 2025 | theglobeandmail.com

QHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025

May 15, 2025 | globenewswire.com

USA Equities Engages Hayden IR for Investor Relations

February 26, 2025 | tipranks.com

QHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations Program

February 26, 2025 | globenewswire.com

QHSLab’s Record Revenue Growth and First Profitable Year

February 18, 2025 | tipranks.com

QHSLab, Inc. Reports Record Revenue Growth and Positive Net Income in Preliminary Q4 and FY 2024 Financial Results

February 18, 2025 | globenewswire.com

QHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic Growth

February 11, 2025 | globenewswire.com

USA Equities Highlights 2025 Corporate Presentation

January 21, 2025 | tipranks.com

USA Equities to Exhibit at Pri-Med South Conference

January 16, 2025 | tipranks.com

USA Equities Outlines Growth Strategy Amid Challenges

December 17, 2024 | markets.businessinsider.com

QHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE Technology

December 13, 2024 | globenewswire.com

QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024

November 25, 2024 | globenewswire.com

QHSLab, Inc. (OTCQB: USAQ) Reports Record Q3 2024 Revenues, Reflecting Accelerated Expansion in Digital Health and Allergy Diagnostics

November 14, 2024 | globenewswire.com

US election latest: Harris set to give first speech since Trump's election win

November 7, 2024 | news.sky.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

USAQ, HSCS, PAVM, and SSKN Company Descriptions

HeartSciences NASDAQ:HSCS

$3.65 -0.06 (-1.62%)

Closing price 04:00 PM Eastern

Extended Trading

$3.58 -0.06 (-1.78%)

As of 06:55 PM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

PAVmed NASDAQ:PAVM

$0.47 +0.05 (+11.33%)

Closing price 03:59 PM Eastern

Extended Trading

$0.46 -0.01 (-2.05%)

As of 07:55 PM Eastern

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Strata Skin Sciences NASDAQ:SSKN

$1.77 +0.02 (+1.14%)

Closing price 03:17 PM Eastern

Extended Trading

$1.74 -0.03 (-1.69%)

As of 07:53 PM Eastern

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

QHSLab OTCMKTS:USAQ

$0.19 0.00 (0.00%)

As of 08/20/2025 11:43 AM Eastern

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time